无症状的主动脉瓣狭窄(aortic valve stenosis,AS)患者的高血压治疗研究较少。研究人员获取依折麦布辛伐他汀治疗主动脉瓣狭窄(the simvastatin ezetimibe in aortic stenosis,SEAS)研究的试验数据,来评估该类疾病患者的最佳血压水平。方法:对无症状AS和无明显动脉粥样硬化疾病患者1767例进行分析。主要观察指标是全因死亡率、心血管死亡、心脏 Asymptomatic aortic valve stenosis (aortic valve stenosis, AS) patients with less research on the treatment of hypertension. The researchers obtained trial data from the simvastatin ezetimibe in aortic stenosis (SEAS) study to assess the optimal blood pressure level in patients with such diseases. Methods: 1767 patients with asymptomatic AS and no obvious atherosclerosis were analyzed. The main observation indicators are all-cause mortality, cardiovascular death, and heart